Ping’an Ding
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Gastric Cancer Management and Outcomes 26
- Metastasis and carcinoma case studies 7
-
- Circular RNAs in diseases 12
- Co-authors
- Lingjiao Meng (25 shared papers)Meixiang Sang (11 shared papers)Qun Zhao (49 shared papers)Peigang Yang (42 shared papers)Yuan Tian (40 shared papers)Honghai Guo (30 shared papers)Yishui Lian (4 shared papers)Chenyu Sun (15 shared papers)
- Journals
- Frontiers in Oncology (7 papers)Frontiers in Nutrition (6 papers)BMC Cancer (4 papers)Advanced Science (3 papers)BMC Gastroenterology (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ping’an Ding
67 papers receiving 1.1k citations
Ping’an Ding's Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 300
- Oncology 251
- Gastroenterology 45
- Pulmonary and Respiratory Medicine 194
- Molecular Biology 419
Countries citing papers authored by Ping’an Ding
This map shows the geographic impact of Ping’an Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping’an Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping’an Ding more than expected).
Fields of papers citing papers by Ping’an Ding
This network shows the impact of papers produced by Ping’an Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping’an Ding. The network helps show where Ping’an Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping’an Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 132 | |
| 2 | Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks Hit paper breakdown → | 2024 | 104 |
| 3 | 2022 | 101 | |
| 4 | 2018 | 75 | |
| 5 | 2019 | 56 | |
| 6 | 2018 | 53 | |
| 7 | 2023 | 38 | |
| 8 | 2022 | 35 | |
| 9 | 2022 | 34 | |
| 10 | 2022 | 29 | |
| 11 | 2022 | 27 | |
| 12 | 2022 | 26 | |
| 13 | 2022 | 24 | |
| 14 | 2024 | 22 | |
| 15 | 2018 | 21 | |
| 16 | 2022 | 17 | |
| 17 | 2023 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2023 | 14 | |
| 20 | 2022 | 13 |
About Ping’an Ding
Ping’an Ding is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Gastroenterology, having authored 71 papers that have together received 1.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (26 papers), Circular RNAs in diseases (12 papers), MicroRNA in disease regulation (9 papers), Gastrointestinal Tumor Research and Treatment (7 papers), Metastasis and carcinoma case studies (7 papers), Nutrition and Health in Aging (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (300 citations), Oncology (251 citations), Gastroenterology (45 citations), Pulmonary and Respiratory Medicine (194 citations) and Molecular Biology (419 citations). Ping’an Ding has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lingjiao Meng, Meixiang Sang, Qun Zhao, Peigang Yang, Yuan Tian, Honghai Guo, Yishui Lian, Chenyu Sun, Lina Gu and Sihua Liu. Their work appears in journals such as Frontiers in Oncology, Frontiers in Nutrition, BMC Cancer, Advanced Science and BMC Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.